Inovio Pharmaceuticals Inc (NASDAQ: INO) on Friday, soared 5.13% from the previous trading day, before settling in for the closing price of $1.95. Within the past 52 weeks, INO’s price has moved between $1.42 and $13.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 63.34%. The company achieved an average annual earnings per share of 48.40%. With a float of $36.42 million, this company’s outstanding shares have now reached $36.67 million.
Let’s determine the extent of company efficiency that accounts for 134 employees. In terms of profitability, gross margin is -636.81%, operating margin of -11541102.4%, and the pretax margin is -20624824.93%.
Inovio Pharmaceuticals Inc (INO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Inovio Pharmaceuticals Inc is 0.70%, while institutional ownership is 37.15%.
Inovio Pharmaceuticals Inc (INO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 48.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.09% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Inovio Pharmaceuticals Inc (INO) is currently performing well based on its current performance indicators. A quick ratio of 2.63 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 268.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.19, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -1.72 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Looking closely at Inovio Pharmaceuticals Inc (NASDAQ: INO), its last 5-days average volume was 0.63 million, which is a drop from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 81.12%. Additionally, its Average True Range was 0.12.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 64.95%, which indicates a significant decrease from 97.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.32% in the past 14 days, which was lower than the 71.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.82, while its 200-day Moving Average is $3.88. However, in the short run, Inovio Pharmaceuticals Inc’s stock first resistance to watch stands at $2.09. Second resistance stands at $2.14. The third major resistance level sits at $2.21. If the price goes on to break the first support level at $1.97, it is likely to go to the next support level at $1.90. Should the price break the second support level, the third support level stands at $1.85.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
Market capitalization of the company is 75.18 million based on 36,674K outstanding shares. Right now, sales total 220 K and income totals -107,250 K. The company made 120 K in profit during its latest quarter, and -19,380 K in sales during its previous quarter.
